Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 19, 2026
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial.
Journal: Nature communications
Published: December 02, 2025
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.
Journal: Nature communications
Published: June 25, 2025
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.
Journal: Nature communications
Published: June 25, 2025
End-Of-Life Outcomes and Healthcare Utilization for Patients With Hepatocellular Carcinoma Who Received Immune Checkpoint Inhibition.
Journal: Cancer medicine
Published: May 08, 2025
Tumor site influences efficacy of MEKi and immunotherapy combinations in a preclinical model of cholangiocarcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: November 08, 2024
Multidisciplinary Care and Multimodal Treatment Approaches for Unresectable Hepatocellular Carcinoma.
Journal: Advances in oncology
Published: June 17, 2024
Contemporary Systemic Therapy Approaches for Unresectable Hepatocellular Carcinoma.
Journal: Advances in oncology
Published: June 17, 2024
Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma.
Journal: Current treatment options in oncology
Published: November 19, 2023
Last Updated: 09/26/2026